Your browser doesn't support javascript.
loading
Novel Strategy to Combat Antibiotic Resistance: A Sight into the Combination of CRISPR/Cas9 and Nanoparticles.
Wan, Fen; Draz, Mohamed S; Gu, Mengjie; Yu, Wei; Ruan, Zhi; Luo, Qixia.
Afiliación
  • Wan F; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
  • Draz MS; College of Laboratory Medicine, Hangzhou Medical College, Hangzhou 310003, China.
  • Gu M; Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
  • Yu W; Department of Electrical and Computer Engineering, Tufts University, Medford, MA 02155, USA.
  • Ruan Z; Department of Mechanical Engineering, Rice University, Houston, TX 77005, USA.
  • Luo Q; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA.
Pharmaceutics ; 13(3)2021 Mar 08.
Article en En | MEDLINE | ID: mdl-33800235
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza